Literature DB >> 19750571

Effect of early propranolol administration on portal hypertensive gastropathy in cirrhotic rats.

Savas Rafailidis1, Charalampos Demertzidis, Konstantinos Ballas, Michail Alatsakis, Nikolaos Symeonidis, Theodoros Pavlidis, Kyriakos Psarras, Valentini Tzioufa-Asimakopoulou, Athanassios Sakadamis.   

Abstract

AIM: To investigate any protective effect of early propranolol administration in the development of portal hypertensive gastropathy in cirrhotic rats.
METHODS: For the development of liver cirrhosis and portal hypertensive gastropathy, 60 rats underwent ligation of the left adrenal vein and complete devascularization of the left renal vein, followed by phenobarbital and carbon tetrachloride (CCl(4)) administration. After two weeks of CCl(4) administration, the rats were randomly separated into two groups. In group A, propranolol was continuously administered intragastrically throughout the study, whereas in group B normal saline (placebo) was administered instead. Hemodynamic studies and vascular morphometric analysis of gastric sections were performed after complete induction of cirrhosis.
RESULTS: Vascular morphometric studies showed higher numbers of vessels in all mucosal layers in the control group. Statistical analysis revealed a significantly higher total vascular surface in the control group compared to the propranolol group, but with no statistically significant difference between the mean vascular surfaces between the groups. Our study clearly shows that the increased mucosal blood flow is manifested by a marked increase of vessel count.
CONCLUSION: Early propranolol's administration in portal hypertensive cirrhotic rats seems to prevent intense gastric vascular congestion that characterizes portal hypertensive gastropathy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19750571      PMCID: PMC2744184          DOI: 10.3748/wjg.15.4284

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  43 in total

1.  Prevention of portal hypertension and portosystemic shunts by early chronic administration of clonidine in conscious portal vein-stenosed rats.

Authors:  H C Lin; O Soubrane; D Lebrec
Journal:  Hepatology       Date:  1991-08       Impact factor: 17.425

Review 2.  Pathophysiology of portal hypertension.

Authors:  T K Gupta; L Chen; R J Groszmann
Journal:  Baillieres Clin Gastroenterol       Date:  1997-06

Review 3.  Causes and pathomechanisms of oesophageal varices development.

Authors:  K J Paquet
Journal:  Med Sci Monit       Date:  2000 Sep-Oct

4.  Effect of experimentally induced liver cirrhosis on wound healing of the post-extraction tooth socket in rats.

Authors:  M Karalis; T E Pavlidis; K Psarras; K Ballas; T Zaraboukas; S Rafailidis; N Symeonidis; G N Marakis; A K Sakantamis
Journal:  Eur Surg Res       Date:  2007-11-12       Impact factor: 1.745

5.  Effects of a somatostatin analogue SMS 201-995 on hepatic haemodynamics in the pig and on intravariceal pressure in man.

Authors:  S A Jenkins; J N Baxter; W A Corbett; R Shields
Journal:  Br J Surg       Date:  1985-12       Impact factor: 6.939

Review 6.  Severe portal hypertensive gastropathy and antral vascular ectasia are distinct entities in patients with cirrhosis.

Authors:  J L Payen; P Calès; J J Voigt; S Barbe; C Pilette; L Dubuisson; H Desmorat; J P Vinel; A Kervran; J A Chayvialle
Journal:  Gastroenterology       Date:  1995-01       Impact factor: 22.682

7.  Morphology of gastric microcirculation in cirrhosis.

Authors:  M Hashizume; K Tanaka; K Inokuchi
Journal:  Hepatology       Date:  1983 Nov-Dec       Impact factor: 17.425

Review 8.  Portal Hypertensive gastropathy.

Authors:  Paul J Thuluvath; Hwan Y Yoo
Journal:  Am J Gastroenterol       Date:  2002-12       Impact factor: 10.864

9.  Propranolol ameliorates the development of portal-systemic shunting in a chronic murine schistosomiasis model of portal hypertension.

Authors:  S K Sarin; R J Groszmann; P G Mosca; M Rojkind; M J Stadecker; R Bhatnagar; A Reuben; Y Dayal
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

10.  Gastric mucosa in patients with portal hypertension: prevalence of capillary dilatation and Campylobacter pylori.

Authors:  P N Foster; J I Wyatt; D W Bullimore; M S Losowsky
Journal:  J Clin Pathol       Date:  1989-09       Impact factor: 3.411

View more
  1 in total

1.  A randomized controlled study of fuzheng huayu capsule for prevention of esophageal variceal bleeding in patients with liver cirrhosis.

Authors:  Jie Gu; Qin Zhang; Dongying Xue; Hong Cai; Lieming Xu
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-21       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.